BioElectronics Corporation's Chairman Updates Investors

Barchart · 10/16 07:45

Outlines Sales Activities, Clinical Trials, and a Potential Legal Action Against MundiPharma

FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its Chairman, Richard Staelin, PhD.

Read more at globenewswire.com